Uncategorized

FDA approves once-daily HIV pill from Merck

Published

on

A new HIV treatment will soon come to market, and it will spearhead Merck’s attempt to be one of the leading drugmakers in a field many biotechs have deserted.

The FDA greenlit …

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version